ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Željko Reiner, Alberico L. Catapano, Guy De Backer et al.|European Heart Journal|2011Cited by 3.5k
Rosuvastatin in Older Patients with Systolic Heart FailureJohn Kjekshus, John Wikstrand, Eduard Apetrei et al.|New England Journal of Medicine|2007Cited by 1.5k
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureÅke Hjalmarson, for the MERIT-HF Study Group, Sidney Goldstein et al.|JAMA|2000Cited by 1.4k
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trialsJane Armitage, Martin Landray, Colin Baigent et al.|The Lancet|2019Cited by 785
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trialsJohn G.F. Cleland, Karina V Bunting, Marcus Flather et al.|European Heart Journal|2017Cited by 643